Clinical trial

Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity

NCT00553852

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-07-01

PhasePHASE3

Study timeline

Study start (unknown)2007-07-01Date precision: month

Registry last updated2008-03-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

GHDunresolved

Interventions

Recombinant GH Saizen (Merck-Serono)DRUG

Sponsors & collaborators

Federico II Universitylead sponsor

Mapped research locations

NaplesItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00553852 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.